SCHEMBL8357376

SCHEMBL8357376

Bc1ccc(OCc2ccccc2)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 1/20 0.48
MRGPRX4 Q96LA9 4/20 0.47
KDM1A O60341 7/20 0.46
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ERN1 O75460 1/20 0.44
NPC1 O15118 1/20 0.43
PTGER1 P34995 1/20 0.43
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
LIPE Q05469 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30723279 1.00 S1PR5 (0.48) S1PR5MRGPRX4KDM1AMAPTMAPK1
SCHEMBL20807100 0.84 MAPT (0.48) MAPTMAPK1TDP1L3MBTL1NPC1
SCHEMBL30719648 0.82 MRGPRX4 (0.53) S1PR5MRGPRX4KDM1AMAPTMAPK1
SCHEMBL412514 0.82 MRGPRX4 (0.53) S1PR5MRGPRX4KDM1AMAPTMAPK1
SCHEMBL1128800 0.81 S1PR5 (0.52) S1PR5MRGPRX4KDM1AERN1NPC1
SCHEMBL10176688 0.81 FFAR4 (0.57) MRGPRX4MAPTMAPK1TDP1L3MBTL1
SCHEMBL371725 0.79 MAOB (0.53) S1PR5MRGPRX4KDM1AMAPTL3MBTL1
SCHEMBL12260990 0.79 NPC1 (0.56) MRGPRX4MAPTMAPK1TDP1L3MBTL1
SCHEMBL224277 0.79 KDM1A (0.55) S1PR5KDM1APTGER1
SCHEMBL30739242 0.79 KDM1A (0.55) S1PR5KDM1APTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106242973-A Polymerizable compounds and their use in liquid crystal displays 默克专利股份有限公司 2016-12-21 CN disclosed
EP-2352374-B1 NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS MERCK SHARP & DOHME (US) 2014-09-24 EP disclosed
WO-2003053915-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2003-07-03 WO disclosed